High-grade active pharmaceutical ingredients and regulatory-ready intermediates formulated to bypass international supply bottlenecks.
The global pharmaceutical supply chain is undergoing structural shifts, none more profound than inside the Russian Federation. Guided by national programs like "Pharma 2030" (Фарма-2030), Russian drug manufacturers and chemical processing complexes are rapidly transitioning toward local, vertically integrated synthesis of Active Pharmaceutical Ingredients (APIs). In this industrial climate, relying solely on generic finished dosages imports is being superseded by local chemical processing of complex molecules.
Establishing strategic channels with modern chemical synthesis factories capable of delivering highly pure API intermediates is a key success factor. Shanxi Kawsana Health Co., Ltd. sits at this cross-section. Backed by decade-long refining and extraction experience, we provide structural chemical intermediates, custom chiral compounds, and critical excipients that align with both Russian and Eurasian Economic Union (EAEU) regulatory guidelines.
Unlike standard trading operations, our manufacturing facility operates in close proximity to the mineral and chemical resource hubs of Shanxi Province. This proximity grants us a distinct cost-efficiency, continuous raw material supply, and a direct logistics corridor via the overland China-Russia rail networks (such as the Chengdu-Manzhouli-Moscow lines). This mitigates maritime freight vulnerabilities and guarantees supply continuity for critical Russian synthesis operations.
On a global scale, the synthesis of API compounds demands a tight balance between strict quality control and cost-containment. Our facility maintains a certified GMP-compliant system spanning 12,000 square meters alongside a 600-square-meter analytical R&D center. Our technology platforms specialize in selective chlorination, high-pressure hydrogenation, low-temperature crystallization, and complex biological extractions.
Within Russia's borders, these capabilities directly address the market need for primary intermediates. By supplying high-purity precursors, such as 3-Chlorophthalic Anhydride and 3-Chloro-1,2-propanediol, we enable Russian domestic factories to synthesize final pharmacopoeial molecules locally. This contributes to Russia's self-reliance objectives and minimizes overall logistics costs.
High-capacity operational scale designed to meet rigid supply contracts for Russian pharmaceutical and industrial firms.
Navigating cross-border transactions and customs processing requires deep familiarity with local regulatory standards. Our dedicated export management desk ensures that every batch dispatched to Moscow, St. Petersburg, Novosibirsk, or Kazan complies with EAEU technical regulations.
We provide full verification portfolios, including DMFs (Drug Master Files), Certificate of Analysis (CoA) matching USP/EP/BP standards, MSDS, and sanitary certification. For clients transitioning to Russian local registrations, our regulatory team cooperates closely to deliver raw material dossiers required by the Russian Ministry of Health (Minzdrav).
Addressing current geopolitical and banking shifts, Kawsana Health works with direct Ruble-RMB clearing banks and cross-border payment networks (CIPS). This minimizes transaction processing delays. Geographically, our proximity to cross-border routes supports transport via direct rail freight, minimizing port disruptions and guaranteeing container delivery in under 20 days.
A breakdown of the quality assurance and raw material processing sequence implemented inside our factory.
Our catalog is strategically structured to support not just human health formulations, but industrial, veterinary, and petrochemical domains.
With clinical demand rising for anti-diarrheal and gastrointestinal adsorbents inside Russia, high-purity Diosmectite Powder API serves as the foundational active compound. Our synthesis route ensures minimal heavy metal values, surpassing the stringent requirements of local drug manufacturers.
Russia’s vast petroleum sector relies heavily on high-performance chemical additives. Our Polyacrylamide (PAM) raw materials are specifically processed to withstand saline, low-temperature reservoir conditions characteristic of Siberian oilfields, serving as viscosity modifiers and wastewater purifiers.
In Russia’s expanding agricultural and beekeeping sectors, biological health is key. Solutions such as Api-Bioxal provide vital defense mechanisms against parasitic infections like the Varroa mite, securing apiary production across the agricultural regions of southwestern Russia.
Building local production resilience and green chemistry channels for long-term bilateral growth.
Transitioning primary intermediate lines (like 3-Chlorophthalic Anhydride) to continuous flow microchannel reactors to improve yields and minimize energy consumption.
Updating all analytical methods at our Shanxi QC Center to directly conform with State Pharmacopoeia of the Russian Federation (14th & 15th Editions).
Establishing bonded warehouse depots in Vladivostok and Moscow to enable localized distribution of high-demand excipients and bio-extracts.
Shanxi Kawsana Health Co., Ltd. is a professional manufacturer and global supplier of natural botanical extracts, herbal ingredients, synthesized API intermediates, and functional health products. With more than 10 years of industry experience, we are committed to providing high-quality plant-based ingredients, chemical compounds, and comprehensive OEM/ODM solutions for customers worldwide.
Located in Shanxi Province, China, our company operates modern production facilities equipped with advanced extraction, purification, synthesis, and drying technologies. Our GMP-compliant manufacturing workshop covers over 12,000 square meters, supported by a 600-square-meter R&D and Quality Control Center. Backed by an experienced team of production technicians, synthesis specialists, and quality management professionals, we ensure every batch meets stringent international quality standards.
To better serve our global partners, we provide one-stop solutions covering product development, customized formulations, ingredient sourcing, laboratory testing, quality documentation, private labeling, packaging design, regulatory support, and international logistics. Whether you require bulk ingredients or finished products, our professional team is dedicated to delivering reliable, efficient, and customized services.
Quality is the cornerstone of our business. Every batch undergoes rigorous testing using advanced analytical instruments such as HPLC, UV, GC, and microbiological analysis to ensure purity, potency, safety, and consistency. Our quality management system complies with international standards, enabling us to meet the requirements of customers in highly regulated markets.
Today, Shanxi Kawsana Health Co., Ltd. exports its products to more than 40 countries and regions, including Europe, North America, South America, Australia, Southeast Asia, the Middle East, and Russia. Through continuous innovation, strict quality control, and customer-oriented service, we have established long-term partnerships with pharmaceutical companies, dietary supplement manufacturers, and distributors around the world.
Explore our industrial and laboratory-scale compounds, certified for performance and purity.
Answering key queries related to technical specifications, Russian logistics routing, and compliance protocols.
Get in touch with our team of synthesis engineers and logistics managers to request pricing structures, customized specifications, and contract terms.
Send Inquiry Now
Kawsana Health
